Pharmaceutical industry – Page 52

Business
Amylin headquarters to close with further job losses

2013-04-04T00:00:00Z

Bristol-Myers Squibb plans to shutter the San Diego, US, site following last year’s merger
Opinion
From lab to leader

2013-04-02T00:00:00Z

Derek Lowe asks (with some trepidation): do drug companies need scientists at the top?
Business
Russian investment vehicle sets sights on innovative drugs

2013-03-27T00:00:00Z

Rusnano hopes to make a killing by investing in new technologies in the pharmaceutical sector
Business
Court convicts ex-Aptuit researcher over drug data

2013-03-21T00:00:00Z

Altered liquid chromatography results at Scottish site lead to first successful good lab practice prosecution
Business
AstraZeneca partners with Moderna for $240 million

2013-03-21T00:00:00Z

Pharma company sheds more jobs and backs messenger RNA therapeutics
Business
Global AstraZeneca restructuring will cost 1600 jobs

2013-03-19T00:00:00Z

Firm will focus drug development efforts in three strategic R&D centres in the UK, Sweden and the US
Business
Interpol teams up with pharma

2013-03-18T00:00:00Z

Pharmaceutical crime programme will seek to reduce trade in fake drugs
Opinion
New antibiotics: what's the hold up?

2013-03-06T00:00:00Z

It’s more a research problem, than a commercial one, says Derek Lowe
Business
Alcohol dependence pill approved in EU

2013-03-05T00:00:00Z

Selincro tablets from Lundbeck designed to reduce consumption of alcohol
Business
UK considers patent rule change for trials

2013-03-04T00:00:00Z

Government to change law that organisations say makes the country less appealing as a location for clinical trials
Business
Talk of a $6.6bn deal for Elan

2013-02-27T00:00:00Z

Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
Business
$595m octreotide deal grabs Roche

2013-02-21T00:00:00Z

Company will get worldwide rights to oral formulation of growth hormone drug
Business
Merck resolves Vytorin case for $688m

2013-02-19T00:00:00Z

Investors say the company knew about Enhance trial failure but withheld information
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Business
Biogen buys Tysabri from Elan for $3.25bn

2013-02-08T00:00:00Z

Elan earns huge cash injection for blockbuster drug
Business
GSK commits to AllTrials data disclosure

2013-02-07T00:00:00Z

Company will begin publishing all clinical study reports
Business
Zoetis IPO launches at $2.2bn

2013-02-01T00:00:00Z

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
Opinion
Name reactions: how does the label stick?

2013-01-25T00:00:00Z

Derek Lowe investigates the long running tradition of naming reactions after their inventors
Business
Allergan buys MAP for $958m

2013-01-25T00:00:00Z

Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
Business
Vasella to leave Novartis in August

2013-01-24T00:00:00Z

Long serving chair of the board of directors will be succeeded by Jörg Reinhardt